The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation

NCT04377750 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Covid19 Pneumonia

Interventions

DRUG: Tocilizumab

Sponsor

Hadassah Medical Organization

Collaborators

[object Object]
[object Object]